The investment will enable the London-based company to consolidate its position in the UK market and expand its presence in France, where it launched earlier this month. The funding will allow Semble to remain at the forefront of innovation by further driving automation and integration capabilities, covering the needs of small and large operators, and harnessing the power of AI.

Semble was founded by second-time founders, Christoph Lippuner and Mikael Landau, after successfully exiting their previous startup. Having witnessed firsthand the challenges in the healthcare sector, they founded Semble with the conviction that reducing the administrative burden on medical professionals and fostering a more connected ecosystem would lead to better patient outcomes.

In the UK, the current healthcare system relies on outdated technology to function, with a report from the British Medical Association estimating that doctors in England lose 13.5 million working hours a year to inadequate IT systems. Semble is on a mission to change this through its all-in-one clinical system. The system enables healthcare businesses to automate tasks, while providing secure patient data exchange by integrating with third-party systems, such as hospitals, laboratories and pharmacies. Allowing for greater adaptability in the delivery of patient care.

Since its launch in 2018, Semble has experienced rapid growth, its platform is now being used by over 10,000 healthcare professionals across more than 70 specialties. It is a market leader amongst independent clinics and is increasingly being adopted by large operators as they seek ways to enhance efficiency and integrate their systems with an agile solution.

Christoph Lippuner, CEO, said: “Amplifying the impact of healthcare professionals is central to our mission. For too long, they have worked with outdated systems that take them away from what matters most – the patient. With this latest funding, we are looking to bring Semble to professionals across the UK and France, empowering them to spend more time on patient care. We will continue to invest heavily in workflow automation and integrations, positioning Semble at the forefront of AI-driven solutions, and ultimately creating a more connected healthcare ecosystem.”

Alex Gwyther of Mercia Ventures added: “The healthcare market is experiencing significant growth, but the industry’s continued reliance on legacy systems poses a real threat to its future. Semble is pioneering an all-in-one clinical system that enables healthcare businesses to automate many aspects of their practice. This investment will help Semble accelerate product development and expand its presence in the UK and France, empowering healthcare organisations to deliver on their digital transformation and transform their patients' experience. With the founders’ first-hand understanding of the challenges in the healthcare sector and its rapid growth to date, we are in no doubt that Semble is well poised to seize this massive market opportunity.”  

This latest Series B round brings the total raised to $27 million. Semble now has a team of around 80 people, with over half focused on product development. The company has rapidly grown both revenue and customers over the past two years and now looks to continue this strong trajectory in the next stage of its development. 

For more startup news, check out the other articles on the website, and subscribe to the magazine for free. Listen to The Cereal Entrepreneur podcast for more interviews with entrepreneurs and big-hitters in the startup ecosystem.